These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6271561)

  • 1. Suppressive effect of cholecystokinin and its related peptides on beta-endorphin-induced catalepsy in rats.
    Itoh S; Katsuura G
    Eur J Pharmacol; 1981 Sep; 74(4):381-4. PubMed ID: 6271561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caerulein and cholecystokinin suppress beta-endorphin-induced analgesia in the rat.
    Itoh S; Katsuura G; Maeda Y
    Eur J Pharmacol; 1982 Jun; 80(4):421-5. PubMed ID: 6286327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of beta-endorphin, thyrotropin-releasing hormone and cholecystokinin on body shaking behavior in rats.
    Itoh S; Katsuura G
    Jpn J Physiol; 1982; 32(4):667-75. PubMed ID: 6294391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of beta-endorphin effects by cholecystokinin antiserum in rats.
    Itoh S; Katsuura G; Yoshikawa K; Rehfeld JF
    Can J Physiol Pharmacol; 1985 Jan; 63(1):81-3. PubMed ID: 3157433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of beta-endorphin effects by proglumide in rats.
    Katsuura G; Itoh S
    Eur J Pharmacol; 1985 Jan; 107(3):363-6. PubMed ID: 3156751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of cholecystokinin, beta-endorphin, and their antagonists on passive avoidance behavior in rats.
    Itoh S; Katsuura G; Takashima A
    Can J Physiol Pharmacol; 1987 Nov; 65(11):2260-4. PubMed ID: 2966663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of haloperidol-induced catalepsy by cholecystokinin octapeptides after central administration to rats.
    Kádár T; Penke B; Kovács K; Telegdy G
    Neuropharmacology; 1985 Jun; 24(6):577-80. PubMed ID: 2862602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo and in vitro effects of cholecystokinin octapeptide on the release of beta-endorphin-like immunoreactivity.
    Matsumura M; Yamanoi A; Yamamoto S; Saito S
    Neuroendocrinology; 1983 Jun; 36(6):443-8. PubMed ID: 6308491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracerebroventricular cholecystokinin infusions block beta-endorphin-induced disruption of maternal behavior.
    Felicio LF; Mann PE; Bridges RS
    Pharmacol Biochem Behav; 1991 May; 39(1):201-4. PubMed ID: 1924504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analgesia and ptosis caused by caerulein and cholecystokinin octapeptide (CCK-8).
    Zetler G
    Neuropharmacology; 1980 May; 19(5):415-22. PubMed ID: 6248810
    [No Abstract]   [Full Text] [Related]  

  • 11. Fronto-cortical regulation of beta-endorphin actions in the rat.
    Itoh S; Katsuura G
    Peptides; 1985; 6(2):237-40. PubMed ID: 3162160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similarities of the cataleptic state induced by beta-endorphin and morphine.
    Rondeau DB; Turcotte M; Young L; Hebert D
    Pharmacol Biochem Behav; 1982 Oct; 17(4):703-7. PubMed ID: 6294679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of beta-endorphin, vasoactive intestinal polypeptide and cholecystokinin octapeptide on cat carotid chemoreceptor activity.
    McQueen DS; Ribeiro JA
    Q J Exp Physiol; 1981 Jul; 66(3):273-84. PubMed ID: 6166957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cataleptogenic and anticataleptic activity produced by cholecystokinin octapeptides in mice.
    Kádár T; Borda L; Penke B; Kovács K; Telegdy G
    Neuropeptides; 1985 Jun; 6(3):259-68. PubMed ID: 4040614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic mediation of beta-endorphin-induced catalepsy.
    Van Loon GR; Kim C
    Res Commun Chem Pathol Pharmacol; 1978 Jul; 21(1):37-44. PubMed ID: 567367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholecystokinin type A and type B receptor antagonists produce opposing effects on cholecystokinin-stimulated beta-endorphin secretion from the rat pituitary.
    Millington WR; Mueller GP; Lavigne GJ
    J Pharmacol Exp Ther; 1992 May; 261(2):454-61. PubMed ID: 1578360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release of immunoreactive [Met5]enkephalin and cholecystokinin from the spinal cord by beta-endorphin administered intraventricularly in the pentobarbital-anesthetized rat.
    Tseng LF; Huang FY
    Eur J Pharmacol; 1992 May; 215(2-3):309-12. PubMed ID: 1396996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-endorphin induced akinesia in rats: effect of apomorhine and alpha-methyl-p-tyrosine and related modifications of dopamine turnover in the basal ganglia.
    Izumi K; Motomatsu T; Chrétien M
    Life Sci; 1977 Apr; 20(7):1149-55. PubMed ID: 557716
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of cholecystokinin-related peptides on self-stimulation behaviour in rats.
    Balázs M; Schwarzberg H; Penke B; Telegdy G
    Neuropeptides; 1988 Apr; 11(3):143-5. PubMed ID: 3386789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that spinal endorphin mediates intraventricular beta-endorphin-induced tail flick inhibition and catalepsy.
    Tseng LF; Fujimoto JM
    Brain Res; 1984 Jun; 302(2):231-7. PubMed ID: 6329457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.